Pharmaron Beijing Co Ltd Capital Reinvestment Ratio
Pharmaron Beijing Co Ltd capital reinvestment ratio. Pharmaron Beijing Co Ltd (300759) has a Capital Reinvestment Ratio of 0.72x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.04 Billion) in capital expenditures (CN¥746.35 Million). See Pharmaron Beijing Co Ltd (300759) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pharmaron Beijing Co Ltd (2014–2024)
Capital reinvestment ratio of Pharmaron Beijing Co Ltd from 2014 to 2024. This chart tracks Pharmaron Beijing Co Ltd's Capital Reinvestment Ratio across 11 annual periods. See Pharmaron Beijing Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Pharmaron Beijing Co Ltd Capital Reinvestment Ratio by Year (2014–2024)
Pharmaron Beijing Co Ltd capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see 300759 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -23.9% |
| 2023 | 1.04x | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -24.4% |
| 2022 | 1.38x | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +35.4% |
| 2021 | 1.02x | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 0.80x | CN¥1.65 Billion | CN¥1.32 Billion | ▼ -0.7% |
| 2019 | 0.80x | CN¥938.59 Million | CN¥754.61 Million | ▼ -7.5% |
| 2018 | 0.87x | CN¥737.26 Million | CN¥640.99 Million | ▼ -48.6% |
| 2017 | 1.69x | CN¥552.22 Million | CN¥934.67 Million | ▼ -62.2% |
| 2016 | 4.48x | CN¥235.77 Million | CN¥1.06 Billion | ▲ +276.0% |
| 2015 | 1.19x | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥12.13 Million | CN¥81.94 Million | — |